|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/48 | |||
| A61K 47/02 | |||
| A61K 47/10 | |||
| A61K 47/12 | |||
| A61K 47/14 | |||
| A61K 47/18 | |||
| A61K 47/22 | |||
| A61K 47/26 | |||
| A61K 47/32 | |||
| A61K 31/546 | |||
| A61P 31/04 |
| (11) | Number of the document | 2988751 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14788546.1 |
| Date of filing the European patent application | 2014-04-25 | |
| (97) | Date of publication of the European application | 2016-03-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/035454 |
| Date | 2014-04-25 |
| (87) | Number | WO 2014/176501 |
| Date | 2014-10-30 |
| (30) | Number | Date | Country code |
| 201361815932 P | 2013-04-25 | US |
| (72) |
RADHAKRISHNAN, Balasingam, US
VAIDYA, Anuradha, US
|
| (73) |
Seachaid Pharmaceuticals, Inc.,
801 Capitola Drive Suite 5, Durham, NC 27713,
US
|
| (54) | ORAL CEFEPIME COMPOSITIONS AND USES THEREOF |
| ORAL CEFEPIME COMPOSITIONS AND USES THEREOF |